Skip to content
value.today

Adtech Pharma, Inc.

🇺🇸 Warwick, Rhode Island, USAPharmaceuticalsFounded 2020
Total raised
$3 M
2 rounds on record
Latest round
$1 M
Mar 2022
First round on record
Oct 2021
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Adtech Pharma, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Mar 2022$1 MNo. 2Under $2 million

Adtech Pharma, Inc.: Raise no. 2, Mar 2022

Investors in this round

12 investors had bought by the notice of Apr 12, 2022: 12 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $2 M offered; $1 M still to sell
Smallest investment taken
$50,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
$110,500
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Rhode Island

People named in the notice

  • Iok Pang · Executive Officer, Director
  • Lex Adjei · Executive Officer, Director
  • Ping Chang · Executive Officer, Director
  • Robert Kupper · Executive Officer, Director
  • Jodi Brichan · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Spartan Capital Securities, LLC (CRD 146251) · New York, New YorkSold in CO, FL, MA, MS, NJ, NM, NY, OH, RI, SC, WI

Remarks in the notice

  • On fees: “Recipient also received $55,250 as a non-accountable expense allowance.”
  • On the amounts: “Total Offering Amount includes $400,000 which may be sold pursuant to an over-allotment option”

Signed by Robert Kupper, Chief Executive Officer. Source: SEC Form D, newest notice filed Apr 12, 2022. Read the notice at the SEC.

equitySEC
Oct 2021$2 MNo. 1Under $2 million

Adtech Pharma, Inc.: Raise no. 1, Oct 2021

Investors in this round

19 investors had bought by the notice of Nov 9, 2021: 19 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $4 M offered; $2 M still to sell
Smallest investment taken
$50,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
$187,700
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Rhode Island

People named in the notice

  • Iok Wu Pang · Executive Officer, Director
  • Lex Wu Adjei · Executive Officer, Director
  • Ping Wu Chang · Executive Officer, Director · Recipient also received $93,850 as a non-accountable expense allowance
  • Robert Kupper · Executive Officer, Director
  • Jodi Wu Brichan · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Spartan Capital Securities, LLC (CRD 146251) · New York, New YorkSold in CO, CT, FL, ID, IN, MA, NJ, NV, NY, SC, SD, TX, WI

Remarks in the notice

  • On fees: “Recipient also recived $93,850 as a non-accountable expense allowance”
  • On the amounts: “Total Offering Amount includes $325,000 which may be sold pursuant to an over-allotment option”

Signed by Robert Kupper, Chief Executive Officer. Source: SEC Form D, newest notice filed Nov 9, 2021. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Adtech Pharma, Inc. had no revenue when it filed its newest notice of a funding round (Apr 2022).

    SEC Form D (revenue range) · Apr 2022

  • The industry group it chose in its notices: Pharmaceuticals.

    SEC Form D · Apr 2022

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Adtech Pharma, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 19 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Adtech Pharma, Inc.
NameRoleNamed in
Iok PangExecutive officerApr 2022
Lex AdjeiExecutive officerApr 2022
Ping ChangExecutive officerApr 2022
Robert KupperExecutive officerApr 2022
Iok Wu PangExecutive officerNov 2021
Lex Wu AdjeiExecutive officerNov 2021
Ping Wu ChangRecipient also received $93,850 as a non-accountable expense allowanceNov 2021
Iok PangDirectorApr 2022
Jodi BrichanDirectorApr 2022
Lex AdjeiDirectorApr 2022
Ping ChangDirectorApr 2022
Robert KupperDirectorApr 2022
Iok Wu PangDirectorNov 2021
Jodi Wu BrichanDirectorNov 2021
Lex Wu AdjeiDirectorNov 2021
Ping Wu ChangRecipient also received $93,850 as a non-accountable expense allowanceNov 2021